文献速递基础与转化研究临床试验与 GCP

生物工程活细胞构建物激活静脉性小腿溃疡的急性创面愈合反应

A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers.
PubMed 文献 · Sci Transl Med · 2017-01-01

慢性不愈合静脉性小腿溃疡(VLU)治疗手段有限。本研究开展临床试验(NCT01327937),将不愈合VLU患者分为标准治疗(压力治疗)组或生物工程双层活细胞构建物(BLCC)联合标准治疗组,治疗前及治疗后1周采集溃疡边缘组织行微阵列mRNA和蛋白分析。结果显示BLCC治疗溃疡呈现三种转录组模式,提示BLCC诱导从非愈合向愈合组织反应转变,涉及炎症与生长因子信号调节、角质形成细胞活化及Wnt/β-catenin信号减弱。

要点

  • BLCC皮肤替代物联合标准治疗可诱导VLU从非愈合向愈合组织反应转变。
  • 转录组变化涉及炎症与生长因子信号调节、角质形成细胞活化及Wnt/β-catenin信号减弱。
  • BLCC应用使慢性非愈合溃疡微环境转向类似急性愈合创面的独特愈合环境。

核心结论

  • BLCC应用使慢性非愈合溃疡微环境转向类似急性愈合创面的独特愈合环境。
  • 研究为VLU患者提供了可靶向用于设计促进慢性VLU愈合新疗法的体内证据。

研究设计与样本

  • 临床试验(NCT01327937),不愈合VLU患者接受标准治疗(压力治疗)或BLCC联合标准治疗。
  • 治疗前及治疗后1周采集VLU边缘组织,行微阵列mRNA和蛋白综合分析。

主要发现

  • BLCC治疗溃疡呈现三种 distinct 转录组模式。
  • BLCC诱导从非愈合向愈合组织反应转变,涉及炎症与生长因子信号调节、角质形成细胞活化及Wnt/β-catenin信号减弱。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic nonhealing venous leg ulcers (VLUs) are widespread and debilitating, with high morbidity and associated costs; about $15 billion is spent annually on the care of VLUs in the United States. Despite this, there is a paucity of treatments for VLUs because of the lack of pathophysiologic insight into ulcer development as well as the lack of knowledge regarding biologic actions of existing VLU-targeted therapies. The bioengineered bilayered living cellular construct (BLCC) skin substitute is a U.S. Food and Drug Administration-approved biologic treatment for healing VLUs. To elucidate the mechanisms through which the BLCC promotes healing of chronic VLUs, we conducted a clinical trial (NCT01327937) in which patients with nonhealing VLUs were treated with either standard of care (compression therapy) or the BLCC together with standard of care. Tissue was collected from the VLU edge before and 1 week after treatment, and the samples underwent comprehensive microarray mRNA and protein analyses. Ulcers treated with the BLCC skin substitute displayed three distinct transcriptomic patterns, suggesting that BLCC induced a shift from a nonhealing to a healing tissue response, involving modulation of inflammatory and growth factor signaling, keratinocyte activation, and attenuation of Wnt/β-catenin signaling. In these ways, BLCC application orchestrated a shift from the chronic nonhealing ulcer microenvironment to a distinctive healing milieu resembling that of an acute, healing wound. Our findings provide in vivo evidence in VLU patients of pathways that can be targeted in the design of new therapies to promote healing of chronic VLUs.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Stone RC, Stojadinovic O, Rosa AM, et al. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers. Sci Transl Med. 2017. PMID: 28053158. doi:10.1126/scitranslmed.aaf8611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。